Lawangsa, Sahiron J.

HRN: 21-95-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2022
CEFTRIAXONE 1G (VIAL)
10/12/2022
10/19/2022
IV
2g
OD
Infectious Diarrhea
Waiting Final Action 
10/12/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/12/2022
10/19/2022
IV
500mg
Q8
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: